Hippo Holdings Inc.
NYSE:HIPOInsurance - Specialty
+$0.53 today
- Market cap
- $980.48M
- Beta
- 1.52
- P/E (TTM)
- 5.9
- EPS (TTM)
- $4.35
Volume 0.26M
Average 0.11M
HIPO Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Hippo Holdings Inc.NYSE: HIPO
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue declines year over year
Q1 FY2026 cost of revenue of $82.4M fell 32.8% year over year, behind the -30.7% change in trailing-twelve-month cost of revenue. Sequentially, it rose 81.1% from the prior quarter. Over 3 fiscal years it compounded at +8.7% a year.
Context
- Cost of revenue amounted to 49.1% of revenue in FY2025, down 31.0 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -32.8% toward the trailing-twelve-month pace of -30.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 229.9M USD
- Year-over-year change
- -22.8%
- 4-year CAGR
- +21.4%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 229.9M | -22.8% |
| FY2024 | 2024-12-31 | 297.8M | +1.6% |
| FY2023 | 2023-12-31 | 293.1M | +63.7% |
| FY2022 | 2022-12-31 | 179.1M | +69.1% |
| FY2021 | 2021-12-31 | 105.9M | — |
Cost of Revenue vs competitors
How HIPO compares with its peers on the latest reported figures
- HIPO's LTM Mar 2026 cost of revenue of $285.6M is the 7th highest of the 11 companies compared; the peer median is $380.79M.
- Its year-over-year change of -30.7% is the 8th highest of 10, against a peer median of -2.8%.
- Cost of revenue amounts to 59.5% of revenue for HIPO, versus a peer median of 50.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.22B | -35.4% | +218.2% | 40.9% | |
| LTM Mar 2026 | $1.09B | -18.6% | -5.1% | 68.1% | |
| LTM Mar 2026 | $938.76M | -10.4% | -3.5% | 65.8% | |
| LTM Mar 2026 | $567.2M | +1.6% | +6.1% | 65.7% | |
BOWBowhead Specialty Holdings Inc. | LTM Mar 2026 | $382.79M | +26.4% | +43.4% | 65.6% |
| LTM Mar 2026 | $378.78M | -40.3% | -21.9% | 48.8% | |
| LTM Mar 2026 | $285.6M | -30.7% | +8.7% | 59.5% | |
| LTM Mar 2026 | $212.57M | — | — | 45.2% | |
| LTM Mar 2026 | $170.16M | -2.8% | +3.7% | 52.4% | |
| LTM Mar 2026 | $155.56M | +17.6% | +51.5% | 34.1% | |
| LTM Mar 2026 | $24.34M | +25.8% | +68.8% | 14.1% | |
| Peer median (excluding HIPO) | $380.79M | -2.8% | +6.1% | 50.6% | |
Competitors are the stored peer set for HIPO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 91.2M | 119.7M | 209.7M | 372.1M | 468.6M |
| Cost of Revenue | 105.9M | 179.1M | 293.1M | 297.8M | 229.9M |
| Gross Profit | (14.7M) | (59.4M) | (83.4M) | 74.3M | 238.7M |
| Gross Margin | -16.1% | -49.6% | -39.8% | 20.0% | 50.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 151.4M | 173.3M | 159.7M | 121.9M | 100.6M |
| Operating Expenses | 352.5M | 265.8M | 179.1M | 101.7M | 175.4M |
| Depreciation & Amortization | 11M | 15.2M | 19.8M | 23.2M | 20.4M |
| EBITDA | (157.3M) | (310M) | (242.7M) | (4.2M) | 83.7M |
| EBITDA Margin | -172.5% | -259.0% | -115.7% | -1.1% | 17.9% |
| Operating Income | (367.2M) | (325.2M) | (262.5M) | (27.4M) | 63.3M |
| Operating Margin | -402.6% | -271.7% | -125.2% | -7.4% | 13.5% |
| Interest Income | 0 | 2.4M | 7.3M | 9.9M | 0 |
| Interest Expense | 198.9M | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | (367.2M) | (325.2M) | (262.5M) | (27.4M) | 63.3M |
| Pre-Tax Margin | -402.6% | -271.7% | -125.2% | -7.4% | 13.5% |
| Income Tax Expense | 700K | 1.3M | 500K | 1.2M | 700K |
| Net Income | (371.4M) | (333.4M) | (273.1M) | (40.5M) | 57.7M |
| Net Margin | -407.2% | -278.5% | -130.2% | -10.9% | 12.3% |
| EPS (Basic) | (23.77) | (14.35) | (11.58) | (1.64) | 2.28 |
| EPS (Diluted) | (23.77) | (14.35) | (11.58) | (1.64) | 2.22 |
| Weighted Avg Shares | 15.48M | 22.75M | 23.58M | 24.7M | 25.25M |
| Weighted Avg Shares (Diluted) | 15.48M | 22.75M | 23.58M | 24.7M | 26.01M |
Hippo Holdings Inc.
NYSE:HIPO
Intrinsic Alpha fair value
Locked
Current Price
$36.83
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.